Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volixibat for pruritus in primary biliary cholangitis
2021-001389-39Phase 2Active
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary biliary cholangitis (PBC) and cholestatic pruritus comparing Volixibat with Placebo (2 arms). Primary endpoint: Change in Adult ItchRO score (primary). Started Oct 2021; status: active.
02
Drugs
volixibat
03
Conditions
primary biliary cholangitis (PBC)cholestatic pruritus
Beyond the preview
Go deeper on 2021-001389-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001389-39.